Optics Unlimited in Jennings, LA - Ophthalmology

Optics Unlimited is a Ophthalmology based in Jennings, Louisiana. Optics Unlimited is licensed to practice in * (Not Available) (license number ) and their current practice location is 1219 Elton Rd, Jennings, Louisiana. It can be reached at their office (for appointments etc.) via phone at (337) 478-3810.

NPI number for Optics Unlimited is 1558650606 and their current mailing address is 1717 Oak Park Blvd, Suite 1, Lake Charles, Louisiana. Optics Unlimited does not participate in medicare program and thus does not accept medicare assignments. The facility's NPI Number is 1558650606.

Contact Information

	Optics Unlimited
	1219 Elton Rd, Jennings, LA 70546-4135
	(337) 478-3810
	(337) 478-6360

Healthcare Provider's Profile

Full Name	Optics Unlimited
Type	Facility
Speciality	Ophthalmology
Location	1219 Elton Rd, Jennings, Louisiana
Accepts Medicare Assignments	Does not participate in Medicare Program. The facility may not accept medicare assignment.

NPI Data:

NPI Number: 1558650606
Provider Enumeration Date: 03/29/2011
Last Update Date: 03/29/2011

Medical Identifiers

Medical identifiers for Optics Unlimited such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1558650606	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
152W00000X	Optometrist	(* (Not Available))	Secondary
207W00000X	Ophthalmology	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Optics Unlimited is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Optics Unlimited 1717 Oak Park Blvd, Suite 1, Lake Charles, LA 70601-8991 Ph: (337) 478-3810	Optics Unlimited 1219 Elton Rd, Jennings, LA 70546-4135 Ph: (337) 478-3810

News Archive

Use of computer-assisted drug design in drug discovery

Metabasis Therapeutics has announced that on March 27, 2007 at the American Chemical Society 233rd National Meeting and Exposition in Chicago, Dr. M. Rami Reddy presented, "Use of Computer-Assisted Drug Design in Drug Discovery: Limitations and Advantages of Available Computational Methods."

Symphony Technology Group acquires ImpactRx

ImpactRx, the pioneer in measuring the impact of promotion on physician prescribing behavior, announced today that Symphony Technology Group (STG), has acquired a majority ownership interest in the Company. STG is a leading private equity firm with a strategic focus on data, analytics and technology-enabled services companies. Merck Capital Ventures (MCV), the venture capital arm of Merck and one of ImpactRx's existing investors, will maintain its investment in ImpactRx.

Study estimates the asymptomatic transmission rate of novel coronavirus

Infectious disease researchers at The University of Texas at Austin studying the novel coronavirus were able to identify how quickly the virus can spread, a factor that may help public health officials in their efforts at containment.

New, non-invasive way to monitor progression of Parkinson's disease may help improve treatment

A new, non-invasive way to track the progression of Parkinson's disease could help evaluate experimental treatments to slow or stop the disease's progression.

Optics Unlimited - in Jennings, LA